Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_assertion type Assertion NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_head.
- NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_assertion description "[Monitoring the course of disease in six of these patients indicated that a strong acceleration in the elution rate after drug application is possibly linked to the success of the chosen cancer treatment as measured by a decrease in the tumor marker CA12-5 to the normal level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_provenance.
- NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_assertion evidence source_evidence_literature NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_provenance.
- NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_assertion SIO_000772 1394186 NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_provenance.
- NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_assertion wasDerivedFrom befree-20150227 NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_provenance.
- NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_assertion wasGeneratedBy ECO_0000203 NP276906.RA5nBS323TDOENMFnKaI-e8c52y0tUWEPvsu4I0iYVfMI130_provenance.